US Patent Issued to Washington University on Aug. 5 for "Methods for determining therapeutic responsiveness for inflammatory bowel disease therapy" (Missouri Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,379,368, issued on Aug. 5, was assigned to Washington University (St. Louis).

"Methods for determining therapeutic responsiveness for inflammatory bowel disease therapy" was invented by Thaddeus Stappenbeck (St. Louis) and Kelli VanDussen (St. Louis).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of selecting a treatment for an inflammatory bowel disease in a subject. In particular, using an indicator of epithelial absorption and metabolism the present disclosure provides method for determining the likelihood a subject is responsive or non-responsive to an inflammatory bowel disease therapeutic agent. The method inc...